ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Mesoblast Limited 

Level 1, 843A Glenhuntly Road

Caulfield South  VIC  3162  Australia
Phone: 03-9618-7000 Fax:


SEARCH JOBS


Industry
Biotechnology






 Company News
Mesoblast Limited (MSB.AX) Key Patent Allowed In Japan For The Treatment Of Heart Diseases, Stroke, And Other Vascular Conditions 3/27/2015 6:11:36 AM
Mesoblast Limited (MSB.AX) Selected For Fast Track Access To Potential Investment Incentives In Japan 3/19/2015 7:41:05 AM
Improved Survival In Children With Graft Versus Host Disease Who Respond To Mesoblast Limited (MSB.AX)'s Cell Therapy 2/16/2015 8:51:42 AM
Mesoblast Limited (MSB.AX) Reports 2015 Half-Year Results 2/12/2015 7:43:42 AM
Mesoblast Limited (MSB.AX) Reports Positive 24 Month Results In Phase 2 Trial For Chronic Low Back Pain And Initiation Of Phase 3 Program At J.P. Morgan Healthcare Conference 1/15/2015 6:58:54 AM
Mesoblast Limited (MSB.AX)'s Phase 2 Trial Results In Chronic Low Back Pain Presented At North American Spine Society Annual Meeting 11/13/2014 7:28:59 AM
Mesoblast Limited (MSB.AX) Partner JCR Pharmaceuticals Files For Marketing Approval Of The First Allogeneic Stem Cell Product In Japan 10/1/2014 7:51:20 AM
Mesoblast Limited (MSB.AX) Unveils Path To Bring Its Key Products To Market 8/26/2014 7:44:01 AM
Pharmaceutical Executive Joins Mesoblast Limited (MSB.AX) As Chief Financial Officer 8/25/2014 7:42:52 AM
National Institutes of Health (NIH) And Mesoblast Limited (MSB.AX) Enter Into Agreement for 120-Patient Trial In End-Stage Heart Failure 8/7/2014 7:37:11 AM
12345678910...